Switch to:
More From Other Websites
RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers Jul 29 2014
Raptor Pharmaceutical to Hold Second Quarter 2014 Financial Results Webcast and Conference Call Jul 28 2014
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic Jul 24 2014
Long-term calls bullish on Raptor Jul 18 2014
Raptor Pharmaceuticals CEO to Retire, Appoints Successor Jul 08 2014
RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jul 08 2014
Raptor Announces CEO Succession Plan; Dr. Christopher Starr to Retire as CEO at Year-end 2014, Julie... Jul 07 2014
Raptor Pharmaceuticals appoints Julie Anne Smith as president, CEO Jul 07 2014
Raptor Announces CEO Succession Plan; Dr. Christopher Starr to Retire as CEO at Year-end 2014, Julie... Jul 07 2014
RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Jul 03 2014
Raptor Pharmaceutical Enters Into $70 Million Financing Transaction and Amended Loan Agreement With... Jul 02 2014
Raptor Pharmaceutical Enters Into $70 Million Financing Transaction and Amended Loan Agreement With... Jul 01 2014
Data Published in Journal of Pediatrics Demonstrated That PROCYSBI(R) Improved Quality of Life and... Jun 24 2014
Raptor Pharma (RPTP) is in Overbought Territory: What's Next? Jun 16 2014
Raptor Pharmaceutical to Participate in Three Upcoming Investor Conferences in June Jun 10 2014
RAPTOR PHARMACEUTICAL CORP Financials May 21 2014
Raptor Pharmaceuticals CFO buys 16.1K shares May 15 2014
[$$] Is Raptor Pharmaceutical a Dinosaur? May 13 2014
Raptor Pharmaceuticals files automatic mixed securities shelf May 12 2014


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide